India’s semiconductor story is transferring past chip factories. The India Semiconductor Mission (ISM) has already set the inspiration for home chip manufacturing and packaging. With ISM 2.0, the main focus is widening to equipment, supplies and different elements of the semiconductor provide chain. This issues for chemical firms.
Each semiconductor requires specialised chemical compounds at a number of phases of producing. In response to Aether Industries’ management, India’s semiconductor and electronics market is predicted to double from roughly $50 billion right this moment to $110 billion (round ₹10 lakh crore) by 2030. This progress may drive demand for specialised semiconductor chemical compounds.
The chance, nevertheless, is just not solely about supplying chemical compounds. Semiconductor producers require high-purity merchandise, constant high quality and rigorous buyer validation. This creates a excessive entry barrier. However this additionally offers established chemical firms a chance to construct a brand new progress engine.
This text examines three Indian chemical companies diversifying into semiconductor chemicals.
#1 Tatva Chintan Pharma Chemical: Crafting high-purity foundations for microchips.
Tatva Chintan Pharma manufactures area of interest, inexperienced speciality chemical compounds like structure-directing brokers and phase-transfer catalysts. The corporate serves international pharmaceutical, agrochemical, energy storage, and automotive emission management industries.
Join now
Getting into the Excessive-Purity Semiconductor Provide Chain
Within the semiconductor sector, Tatva Chintan Pharma focuses on growing high-purity speciality chemical compounds for 3 distinct functions.
- Key beginning uncooked materials for manufacturing semiconductors (which requires assembly essentially the most stringent and rigorous specs).
- Etching agent for printed circuit boards (PCBs).
- Cleansing agent for circuits.
Throughout Q1FY27, the corporate achieved a milestone by delivering its first plant-scale batch (a couple of tons) of semiconductor materials to a buyer. The client authorised this primary batch to be used as a key beginning block, assembly its most vital specification standards.
Tatva Chintan doesn’t promote on to semiconductor producers or fabrication crops. As an alternative, the corporate provides its supplies to multinational firms, which then package deal the chemical compounds and provide them on to semiconductor producers.
The 2028 Validation Horizon
Altering chemical suppliers within the semiconductor trade is troublesome and requires intensive validation. The corporate might want to conduct no less than three to 4 extra plant-scale trials over the subsequent two years to show consistency in high quality and supply. Solely after profitable validation can it safe large-scale enterprise.
As a consequence of these lengthy validation cycles, Tatva Chintan expects no vital commercialisation or vital quantity gross sales earlier than December 2028. Past the semiconductor enterprise, Tatva Chintan’s enterprise has 4 well-established enterprise verticals. Collectively, these segments generated working income of ₹167.1 crore in Q1 FY27, up 43% from the earlier 12 months.
Core Verticals Drive 43% Q1 Progress
This consists of construction directing brokers (34% of Q1FY27 income), pharma and agrochemical intermediaries (35%), part switch catalysts (26%), electrolyte salts and options (ESS) (4%) and others (1%). The ESS vertical manufactures electrolyte salts utilized in supercapacitor (ultra-capacitor) batteries for electric vehicles, renewable energy, and so on.
#2 Anupam Rasayan: Quick-tracking international semiconductor provide integration.
Anupam Rasayan manufactures life science-related specialty chemical compounds and is increasing into the semiconductor and electronics sectors. To this finish, the acquisition of US-based Jayhawk High-quality Chemical compounds is a key pillar of Anupam Rasayan’s semiconductor technique. It offers the corporate a longtime entry into the semiconductor provide chain.
Quick-Monitoring the Silicon Entry
The acquisition of Jayhawk instantly advances Anupam’s technique by 5-7 years. Jayhawk provides fragrant dianhydrides (each fluorinated and non-fluorinated) and polyimide intermediates to Anupam’s portfolio. These polymers are key supplies utilized in chip packaging, versatile circuits, and superior shows.
It additionally manufactures area of interest molecules designed particularly for the electronics ecosystem. These supplies are utilized in semiconductor processing and show chemical compounds. Jayhawk has long-standing relationships with blue-chip clients worldwide.
In 2024, Jayhawk generated 65% of its income from the Efficiency Materials section. This section serves the semiconductor, defence, vitality and infrastructure, and polymers. In Q1FY27, Jayhawk contributed 20-22% (₹145 crore) to Anupam’s consolidated income, with margins of 19-20% and web revenue of ₹9 crore.
Constructing the Built-in Provide Chain
Concurrently, Anupam’s enterprise in India is presently looking for industrial validation for its semiconductor-focused merchandise. Anupam has designed a completely built-in provide chain that spans uncooked supplies to high-purity finish functions. The acquisition of Tanfac gave it entry to key beginning uncooked supplies like hydrofluoric acid and potassium fluoride.
Uncooked supplies sourced from each Tanfac and Anupam may assist Jayhawk’s US facility. Anupam itself is the primary firm on this planet to commercialise ethyl trifluoroacetate (ETFA) utilizing steady circulate chemistry.
ETFA molecules function key intermediates in pharmaceutical, agrochemical, and particularly within the electronics and semiconductor sectors. ETFA additionally improves purity, enhances security and is environmentally pleasant. Anupam additionally goals to cross-sell its complementary portfolio to Jayhawk’s present semiconductor and electronics buyer community.
The ₹4,000-Crore Consolidation Roadmap
Anupam began FY27 on a robust be aware, pushed primarily by Jayhawk’s consolidation. Income grew 35% year-on-year to ₹655 crore in Q1FY27. EBITDA elevated 35% to ₹174.9 crore, in keeping with the top-line progress, whereas margins stayed flat at 26%. Web revenue grew simply 6% to ₹51.2 crore as a result of non-cash depreciation prices.
Trying forward, as soon as all acquisitions are consolidated, the consolidated entity’s pro-forma income may exceed ₹4,000 crore. This consists of ₹1,676 crore from Anupam Standalone, Tanfac Industries (₹711 crore), Jayhawk (₹722 crore), and Bliss GVS (₹927 crore). EBITDA is predicted to be ₹834 crore.
#3 Aether Industries: Excessive-value chemistry powering next-gen {hardware}.
Aether Industries manufactures the specialty chemical constructing blocks that enable high-speed {hardware} to function with out sign loss or overheating. To do that, {hardware} producers depend on low-dielectric supplies, resins, and coupling brokers.
The Chemistry Behind Excessive-Velocity {Hardware}
These supplies enable high-frequency alerts to move by means of with virtually no sign loss. Aether develops the monomers and coupling brokers that function the uncooked constructing blocks for Silane Coupling Brokers and PPE-type resins.
Silane Coupling Brokers are glues that bond and toughen the glass fibre and resin layers of high-speed circuit boards. PPE-Sort Resins are heat-resistant resins utilized in copper-clad laminates inside Artificial Intelligence servers and 5G base stations. They maintain the {hardware} cool and keep sign integrity.
$50/Kg Area of interest: Panoli Enlargement Plan
Not like most Indian firms within the semiconductor sector, Aether is specializing in capital-light, low-volume, and high-value molecules. Administration estimates a premium common worth of US$50 per kilogram.
Aether is the primary and solely producer in India making these particular molecules. It has already accomplished buyer pattern {qualifications}. It’s actively delivering smaller industrial orders to purchasers in Japan. The principle industrial manufacturing block is coming to its new Magnum website (Website 5) in Panoli.
This stream may have a month-to-month capability of 45 tons and is focused to go surfing by Q3FY27. Aether expects the capability to develop 3X by 2030. Administration has additionally utilized to take part in India’s Semiconductor Mission 2.0.
Contract Manufacturing Drives 31.5% Margin
Aether’s income grew 27% year-on-year to ₹326.6 crore in Q1FY27. This was pushed by 75% progress in contract and unique manufacturing and 20% progress in contract analysis and manufacturing companies. These two high-margin verticals accounted for 60% of the corporate’s income within the quarter. EBITDA elevated 31% to ₹102.8 crore, whereas margins expanded to 31.5%. Web revenue grew 33% to ₹62.7 crore.
Here’s a abstract of the financials of the three firms:-
| Particulars | Tatva Chintan | Anumpam Rasayan | Aether Industries |
| Q1FY27 Income | ₹167.1 | ₹655.0 | ₹326.6 |
| YoY Progress | 43% | 35% | 27% |
| EBITDA (Margin) | 32.3 (19.0%) | 174.9 (26%) | 102.8 (31.5%) |
| Web Revenue | 16.0 | 51.2 | 62.7 |
| YoY Progress | 140% | 6% | 33% |
All three firms delivered robust income progress in Q1FY27. Web revenue progress was additionally good for Tatva and Ather, whereas depreciation prices impacted Anupam’s revenue. Aether additionally stands out for its increased EBITDA margins, whereas Anupam has the most important income base among the many three.
Their semiconductor alternatives are at totally different phases. Tatva Chintan remains to be within the validation part, Anupam Rasayan has gained a foothold by means of Jayhawk, whereas Aether is transferring nearer to industrial manufacturing.
Evaluating Capital Effectivity: Premium Valuations vs Business Medians
Aether Industries boasts a robust Return on Capital Employed (ROCE) and Return on Fairness (ROE), adopted by Anupam and Tatva. Nonetheless, all three firms presently report return ratios under the trade median.
On the valuation entrance, all three are buying and selling at a premium to the trade median. Based mostly on their 3-year historic median, Tata Chintan and Anupam are buying and selling at a reduction, whereas Aether is buying and selling at a premium.
| Peer Comparability (X) | ||||
| Value-to-Earnings A number of | Return Ratios | |||
| Firm | Firm | 3Y Median | ROCE (%) | ROE (%) |
| Tatva Chintan | 70.7 | 92.2 | 7.1 | 5.5 |
| Anupam Rasayan | 82.7 | 85.2 | 7.4 | 5.5 |
| Aether Industries | 90.3 | 83.9 | 11.9 | 9.7 |
| Business | 28.7 | 13.6 | 10.9 | |
| Supply: Screener.in (As of twenty sixth August 2026) | ||||
India’s push into semiconductor chemical compounds opens up an enormous alternative, nevertheless it gained’t yield fast wins. Aether, Anupam Rasayan, and Tatva Chintan are making early strikes by concentrating on high-value niches and locking down international provide chains. That stated, significant income probably gained’t kick in quickly.
In the meantime, it will be value maintaining these on your watchlist.
Disclaimer:
Notice: All through this text, we now have relied on knowledge from http://www.Screener.in and the corporate’s investor presentation. We used another, extensively accepted supply of data solely when the information had been unavailable.
The aim of this text is simply to share attention-grabbing charts, knowledge factors, and thought-provoking opinions. It’s NOT a suggestion. For those who want to contemplate an funding, you’re strongly suggested to seek the advice of your advisor. This text is strictly for academic functions solely.
Concerning the Creator: Madhvendra has been deeply immersed within the fairness markets for over seven years, combining his ardour for investing along with his experience in monetary writing. With a knack for simplifying advanced ideas, he enjoys sharing his trustworthy views on startups, listed Indian firms, and macroeconomic traits.
A devoted reader and storyteller, Madhvendra thrives on uncovering insights that encourage his viewers to deepen their understanding of the monetary world.
Disclosure: The author and his dependents don’t maintain the shares mentioned on this article.
The web site managers, its worker(s), and contributors/writers/authors of articles have or could have an excellent purchase or promote place or holding within the securities, choices on securities or different associated investments of issuers and/or firms mentioned therein. The articles’ content material and knowledge interpretation are solely the private views of the contributors/ writers/authors. Traders should make their very own funding choices primarily based on their particular goals and sources, and solely after consulting any unbiased advisors as crucial.
